Get the Stockscreener App
2.32
6.45%
-0.16
After Hours:
2.38
0.06
+2.59%
Medicus Pharma Ltd stock is traded at $2.32, with a volume of 247.58K.
It is down -6.45% in the last 24 hours and down -3.73% over the past month.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
See More
Previous Close:
$2.48
Open:
$2.48
24h Volume:
247.58K
Relative Volume:
0.65
Market Cap:
$50.76M
Revenue:
-
Net Income/Loss:
$-16.51M
P/E Ratio:
-1.715
EPS:
-1.3528
Net Cash Flow:
$-15.68M
1W Performance:
-7.94%
1M Performance:
-3.73%
6M Performance:
-35.18%
1Y Performance:
+0.00%
1-Day Range:
$2.30
$2.48
1-Week Range:
$2.30
$2.70
52-Week Range:
$1.7901
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
Name
Medicus Pharma Ltd
Sector
Industry
Phone
610-540-7515
Address
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Compare MDCX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
2.32 | 50.76M | 0 | -16.51M | -15.68M | -1.3528 |
|
LLY
Lilly Eli Co
|
819.40 | 747.19B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
190.90 | 459.32B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
230.30 | 407.19B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
129.12 | 251.72B | 53.40B | 13.68B | 16.89B | 6.8864 |
|
MRK
Merck Co Inc
|
85.70 | 214.78B | 63.43B | 16.42B | 14.72B | 6.4861 |
Medicus Pharma Ltd Stock (MDCX) Latest News
What MACD and RSI say about Medicus Pharma Ltd.2025 Analyst Calls & Entry Point Strategy Guides - newser.com
Measuring Medicus Pharma Ltd. Equity Warrant’s beta against major indicesWeekly Profit Report & Long-Term Capital Growth Ideas - newser.com
Pattern recognition hints at Medicus Pharma Ltd. Equity Warrant upsideQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com
Medicus Pharma Ltd. stock trendline breakdownIndex Update & Long-Term Growth Plans - newser.com
Is Medicus Pharma Ltd. Equity Warrant stock a safe buy before earnings2025 Top Gainers & Reliable Price Breakout Signals - newser.com
What technical models suggest about Medicus Pharma Ltd. Equity Warrant’s comebackMarket Risk Analysis & Verified High Yield Trade Plans - newser.com
Medicus Pharma Ltd. Equity Warrant stock momentum explainedJuly 2025 Fed Impact & Free Verified High Yield Trade Plans - newser.com
Medicus Pharma to Showcase Innovations at Maxim Growth Summit 2025 - TipRanks
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025 - ACCESS Newswire
Using data filters to optimize entry into Medicus Pharma Ltd. Equity WarrantJuly 2025 Retail & Safe Capital Preservation Plans - newser.com
How Medicus Pharma Ltd. (N460) stock reacts to Fed tightening2025 Macro Impact & Verified Momentum Watchlists - newser.com
Medicus Pharma Ltd. Announces $8.0 Million Non-Dilutive Debenture Financing - Ashland Times-Gazette
Is Medicus Pharma Ltd. Equity Warrant meeting your algorithmic filter criteriaProduct Launch & Advanced Technical Signal Analysis - newser.com
Candlestick signals on Medicus Pharma Ltd. stock todayAnalyst Upgrade & Scalable Portfolio Growth Methods - newser.com
Should you wait for a breakout in Medicus Pharma Ltd.2025 Historical Comparison & Stepwise Swing Trade Plans - newser.com
Heatmap analysis for Medicus Pharma Ltd. Equity Warrant and competitorsPrice Action & Safe Investment Capital Preservation Plans - newser.com
Is this a good reentry point in Medicus Pharma Ltd.Weekly Market Report & Low Risk Entry Point Guides - newser.com
Medicus Pharma Ltd. To Present at Brookline Capital Markets - Lansing State Journal
Medicus Pharma to acquire Antev - MSN
Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE - Cincinnati Enquirer
Using portfolio simulators with Medicus Pharma Ltd. includedJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com
Price action breakdown for Medicus Pharma Ltd.Earnings Summary Report & Daily Momentum Trading Reports - newser.com
Is Medicus Pharma Ltd. Equity Warrant stock affected by interest rate hikesWeekly Profit Summary & Daily Chart Pattern Signals - newser.com
Medicus Pharma (Nasdaq: MDCX) Nears Surgery-Free Breakthrough in Oncology - openPR.com
Oklahoma City NewsThe Oklahoman - FinancialContent
Key metrics from Medicus Pharma Ltd.’s quarterly dataDollar Strength & Community Driven Trade Alerts - newser.com
Should you hold or exit Medicus Pharma Ltd. now2025 Trade Ideas & Smart Swing Trading Techniques - newser.com
Using economic indicators to assess Medicus Pharma Ltd. potential2025 Major Catalysts & Technical Entry and Exit Tips - newser.com
Measuring Medicus Pharma Ltd.’s beta against major indicesJuly 2025 Volume & Free Community Consensus Stock Picks - newser.com
How Medicus Pharma Ltd. (N460) stock trades in high volatilityMarket Trend Summary & Reliable Momentum Entry Alerts - newser.com
Is Medicus Pharma Ltd. (N460) stock a momentum leaderTake Profit & Verified Momentum Stock Ideas - newser.com
What analysts say about Medicus Pharma Ltd stockProtective Put Strategies & Free Robust Financial Gains - earlytimes.in
Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject - Pueblo Chieftain
Medicus Pharma Ltd Stock (MDCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Medicus Pharma Ltd Stock (MDCX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| VELOCITY FUND PARTNERS, LP | 10% Owner |
May 20 '25 |
Sale |
7.72 |
75,000 |
578,940 |
3,248,741 |
1.48%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):